Search research articles
Contact Us
Filters
Showing results (61-70 of 64) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 64 results.
Journal of the American Geriatrics Society
|
December 23, 2011
Do instrumental activities of daily living predict dementia at 1- and 2-year follow-up? Findings from the Development of Screening guidelines and diagnostic Criteria for Predementia Alzheimer's disease study
Sietske A M Sikkes, Pieter Jelle Visser, Dirk L Knol, et al.
Dementia and Geriatric Cognitive Disorders
|
May 9, 2013
Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study
Marinella Damian, Lucrezia Hausner, Katrin Jekel, et al.
JAMA Neurology
|
May 26, 2018
Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment
David A Wolk, Carl Sadowsky, Beth Safirstein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 25, 2014
The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey
Martina Bocchetta, Samantha Galluzzi, Patrick Gavin Kehoe, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 64) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 64 results.
Journal of the American Geriatrics Society
|
December 23, 2011
Do instrumental activities of daily living predict dementia at 1- and 2-year follow-up? Findings from the Development of Screening guidelines and diagnostic Criteria for Predementia Alzheimer's disease study
Sietske A M Sikkes, Pieter Jelle Visser, Dirk L Knol, et al.
Dementia and Geriatric Cognitive Disorders
|
May 9, 2013
Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study
Marinella Damian, Lucrezia Hausner, Katrin Jekel, et al.
JAMA Neurology
|
May 26, 2018
Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment
David A Wolk, Carl Sadowsky, Beth Safirstein, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 25, 2014
The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey
Martina Bocchetta, Samantha Galluzzi, Patrick Gavin Kehoe, et al.
Page
of 7